Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01192412 · ClinicalTrials.gov registry record · NA
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
A NA study, sponsored by University of British Columbia.
- Completed
- Registry status
- NA
- Development phase
- 987
- Enrollment target
NCT01192412: Completed NA study, sponsored by University of British Columbia.
NCT01192412 is a NA study that has completed, run by University of British Columbia. The registered enrollment target is 987 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01192412, a NA study, has completed, sponsored by University of British Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 987 participants
- Enrollment target
Study Summary
The investigators do not know which approach to treatment of non-severe high blood pressure in pregnancy is better for women and babies. In the CHIPS Trial, the investigators seek to determine whether 'less tight' control (aiming for a diastolic blood pressure \[dBP\] of 100 mmHg), compared with 'tight' control (aiming for a diastolic blood pressure \[dBP\] of 85 mmHg) can decrease the risks of adverse baby outcomes without increasing the risk of problems for the mother.
Primary Outcome
Pregnancy loss or NICU admission for greater than 48 hours, as recorded in the maternal and infant medical records immediately following the birth (or pregnancy loss), and then again after the mothers' and infants' discharge home. Supplemental information, about potential post-discharge maternal or neonatal morbidities in the 6 weeks following birth for the mother, or 28 days of life for the baby, will be obtained by contacting women at 6 weeks postpartum and/or from medical records.
Interventions
- PROCEDURE Intervention is blood pressure management approach
- PROCEDURE Intervention is blood pressure management approach.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 987 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT01192412 record still lists
NCT01192412 is an interventional study that assigns participants to a tested intervention. The registered 987 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 2 interventions - of which Intervention is blood pressure management approach is the first listed.
NCT01192412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01192412 about?
NCT01192412 is a clinical study titled "The CHIPS Trial (Control of Hypertension In Pregnancy Study)". The investigators do not know which approach to treatment of non-severe high blood pressure in pregnancy is better for women and babies. In the CHIPS Trial, the investigators seek to determine whether 'less tight' control (aiming for a diastolic blood pressure \[dBP\] of 100 mmHg), compared with 't...
What is the current status of trial NCT01192412?
This trial is currently completed. It is a NA study. The enrollment target is 987 participants. The study started on 2009-04. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01192412?
The interventions under investigation include: Intervention is blood pressure management approach (PROCEDURE), Intervention is blood pressure management approach. (PROCEDURE).
Who is sponsoring clinical trial NCT01192412?
This trial is sponsored by University of British Columbia, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01192412's enrollment target sits among peer trials
987 122nd of 2000 higher than 1,879 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia